Abstract
Statins are 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors, and this class of drugs has been studied as protective agents against DNA damages. Alkylating agents (AAs) are able to induce alkylation in macromolecules, causing DNA damage, as DNA methylation. Our objective was to evaluate atorvastatin (AVA) antimutagenic, cytoprotective, and antigenotoxic potentials against DNA lesions caused by AA. AVA chemopreventive ability was evaluated using antimutagenicity assays (Salmonella/microsome assay), cytotoxicity, cell cycle, and genotoxicity assays in HepG2 cells. The cells were cotreated with AVA and the AA methyl methanesulfonate (MMS) or cyclophosphamide (CPA). Our datum showed that AVA reduces the alkylation-mediated DNA damage in different in vitro experimental models. Cytoprotection of AVA at low doses (0.1-1.0 μM) was observed after 24 h of cotreatment with MMS or CPA at their LC50, causing an increase in HepG2 survival rates. After all, AVA at 10 μM and 25 μM had decreased effect in micronucleus formation in HepG2 cells and restored cell cycle alterations induced by MMS and CPA. This study supports the hypothesis that statins can be chemopreventive agents, acting as antimutagenic, antigenotoxic, and cy...Continue Reading
References
Mar 1, 1975·Proceedings of the National Academy of Sciences of the United States of America·J McCannB N Ames
Jan 1, 1975·Basic Life Sciences·M Radman
Jun 1, 1992·Mutation Research·S De FloraF H Sobels
Jul 1, 1990·Mutation Research·D T Beranek
Jan 1, 1988·Annual Review of Biochemistry·T LindahlY Nakabeppu
May 1, 1983·Mutation Research·D M Maron, B N Ames
Jun 1, 1995·Mutation Research·V CiaravinoJ C Theiss
Feb 1, 1996·Regulatory Toxicology and Pharmacology : RTP·B Singer
Dec 13, 2000·Mutation Research·K Mortelmans, E Zeiger
Apr 18, 2001·Circulation·I JialalS Devaraj
Nov 9, 2004·Atherosclerosis. Supplements·Akira Endo
Apr 12, 2005·Annual Review of Pharmacology and Toxicology·James K Liao, Ulrich Laufs
Jul 1, 2005·Journal of Radiation Research·Junji IwashitaMasami Watanabe
Jan 6, 2006·Drug Metabolism Reviews·Jing ZhangYi-Zhun Zhu
Apr 28, 2006·Cell Biology and Toxicology·T A Ajith, M Soja
Nov 8, 2006·British Journal of Pharmacology·J DamrotG Fritz
Jun 5, 2007·Nature Protocols·Michael Fenech
May 20, 2008·Toxicology and Applied Pharmacology·Goran GajskiVisnja Orescanin
Oct 7, 2008·Toxicology in Vitro : an International Journal Published in Association with BIBRA·L StankevicinsI Felzenszwalb
Dec 1, 2009·Mutation Research·Ana RossiniLuis Felipe Ribeiro Pinto
Feb 1, 2011·Journal of Molecular Cell Biology·Zhiyuan Shen
Jan 12, 2012·Malaria Journal·Jean-Baptiste SouraudBruno Pradines
Jan 21, 2012·Biochemical Society Transactions·Lifei Fan, Harry Mellor
Jun 2, 2012·International Journal of Biological Macromolecules·George M MekhailNahed D Mortada
Jan 10, 2013·PLoS Pathogens·Patricia A ReisHugo C Castro-Faria-Neto
Mar 19, 2013·Neurochemistry International·Samuel Vandresen-FilhoCarla I Tasca
Mar 13, 2014·Journal of Applied Genetics·Karolina SłoczyńskaAnna M Waszkielewicz
Jul 17, 2015·Evidence-based Complementary and Alternative Medicine : ECAM·Marina L C CaxitoKatia C C Sabino
Feb 3, 2016·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Tatiana V DenisenkoBoris Zhivotovsky
Mar 5, 2016·Journal of Toxicology and Environmental Health. Part a·Elisa Raquel A FerrazIsrael Felzenszwalb
May 29, 2016·Toxicology·A S FernandesI Felzenszwalb
Aug 25, 2016·Toxicology Letters·Felipe S CardosoIsrael Felzenszwalb
Feb 16, 2017·BioMed Research International·Carlos F Araujo-LimaIsrael Felzenszwalb